In this Issue:
Antipsychotics for the treatment of psychosis in schizophrenia
Reading deficits in schizophrenia
Structural brain alterations: schizophrenia and autism
Metabolic and cardiovascular risk factors in patients with schizophrenia
Omega-3 fatty acids + antioxidant for relapse prevention after antipsychotic discontinuation
Impact of long-term antipsychotic use on cognition
Effects of aerobic training on cognitive performance and symptom severity in psychiatric inpatients
Pilot study of naltrexone to counteract antipsychoticassociated weight gain
Vasopressin and oxytocin levels in psychotic disorders
Motivational and cognitive deficits are core features of schizophrenia
Please login below to download this issue (PDF)